What happens after a single surgical intervention for hidradenitis suppurativa? A retrospective claims-based analysis

摘要: Objective Hidradenitis suppurativa (HS) is often treated by surgery. The risk of recurrence after surgery common and the consequences are substantial, but neither has been quantified using a claims database. This study aimed to estimate burden associated with non-curative in HS patients. Methods A retrospective analysis was performed health insurance data from Q1 1999 Q2 2011 US included 2668 adults ≥1 diagnosis claim for skin within 6 months diagnosis. Healthcare resource utilization medical costs were compared multivariate regressions. Results Overall, 46% patients had indicator incidences inpatient, emergency department, outpatient visits 88%, 40%, 30% higher, respectively, vs without (all p < 0.001). Average $11,858 $6427 indicators surgery, respectively. difference $4185 (p < 0.001) mainly driven inpatient (difference = $2685; Limitations Indicators defined based on an empirical algorithm. Conclusions Non-curative occurred almost half all cases represents significant payers terms costs.